Page last updated: 2024-08-26

diosgenin and verapamil

diosgenin has been researched along with verapamil in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, CH; Li, SL; Long, MH; Mao, Q; Shakya, S; Zhu, H; Zhu, SC	1
Lee, EK; Lee, MJ; Moon, SY; Park, SK; Yang, WS	1

Other Studies

2 other study(ies) available for diosgenin and verapamil

Article	Year
Study on the pharmacokinetics profiles of polyphyllin I and its bioavailability enhancement through co-administration with P-glycoprotein inhibitors by LC-MS/MS method. Journal of pharmaceutical and biomedical analysis, 2015, Mar-25, Volume: 107 Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chromatography, Liquid; Cyclosporine; Diosgenin; Humans; Male; Rats; Rats, Sprague-Dawley; Saponins; Tandem Mass Spectrometry; Verapamil	2015
Diosgenin, an Activator of 1,25D3-MARRS Receptor/ERp57, Attenuates the Effects of TNF-α by Causing ADAM10-Dependent Ectodomain Shedding of TNF Receptor 1. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 43, Issue:6 Topics: ADAM10 Protein; Biological Transport; Calcium; Calcium Channels, L-Type; Cell Membrane; Cells, Cultured; Diosgenin; Egtazic Acid; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Microscopy, Confocal; Protein Disulfide-Isomerases; Receptors, Tumor Necrosis Factor, Type I; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Verapamil	2017

Article

Year

Study on the pharmacokinetics profiles of polyphyllin I and its bioavailability enhancement through co-administration with P-glycoprotein inhibitors by LC-MS/MS method.

Journal of pharmaceutical and biomedical analysis, 2015, Mar-25, Volume: 107

Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chromatography, Liquid; Cyclosporine; Diosgenin; Humans; Male; Rats; Rats, Sprague-Dawley; Saponins; Tandem Mass Spectrometry; Verapamil

2015

Diosgenin, an Activator of 1,25D3-MARRS Receptor/ERp57, Attenuates the Effects of TNF-α by Causing ADAM10-Dependent Ectodomain Shedding of TNF Receptor 1.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 43, Issue:6

Topics: ADAM10 Protein; Biological Transport; Calcium; Calcium Channels, L-Type; Cell Membrane; Cells, Cultured; Diosgenin; Egtazic Acid; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Microscopy, Confocal; Protein Disulfide-Isomerases; Receptors, Tumor Necrosis Factor, Type I; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Verapamil

2017